EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing patient-reported adverse events in oncology – a review of the PRO-CTCAE instrument

Knoerzer, Dietrich, Kron, Martina, Schüler, Armin, Huschens, Susanne, Bullinger, Monika

GMS Medizinische Informatik, Biometrie und Epidemiologie · 10.04.2025 · 21 (Doc01) · Doc01

DOI: 10.3205/mibe000273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GMS Medizinische Informatik, Biometrie und Epidemiologie, erschienen am 10.04.2025. Verfasst von Knoerzer und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Patient reporting of adverse events (AE) is still rare in oncological drug development. It should however be a crucial part of clinical studies and medical decision making. The PRO-CTCAE instrument has been generated from observer based AE assessment to represent the patients’ view in 124 items. This review examines the psychometric quality of the PRO CTCAE as tested in selected cancer patient groups and published in core papers.

Method

A literature review identified 3 league papers describing the original development of the PRO-CTCAE. Using the COSMIN quality criteria for patient-reported outcome measures, the psychometric performance of the PRO-CTCAE was systematically examined.

Results

Sufficient information on COSMIN quality standards were only present in 2 of the 10 criteria with EORTC QLQ-C30 used as a validation anchor, providing only limited evidence for reliability or validity. For 5 out of the 10 criteria no information at all is available.

Conclusion

PRO-CTCAE is a useful list of items which has been psychometrically tested on individual item level, but not on a scale level. The development of a measurement model and consecutive psychometric testing is recommended to provide information on test-theoretical performance on the aggregate level including scoring and comparison to reference populations. This would transform the PRO-CTCAE items from a list to a tool which can be used in patient-reported AE assessments within and across oncological trials. Future research should focus on explaining potential differences between physicians and patient ratings, on cross-cultural comparability of the tool, and on the impact of PRO-CTCAE as a unique instrument for patient reported outcomes in clinical research and medical decision making.

Schlagwörter

PRO-CTCAEvalidationCOSMIN criteriapsychometric qualityPRO-CTCAEValidierungCOSMIN-Kriterienpsychometrische Qualität

Zitieren

APA

Knoerzer, Dietrich, Kron, Martina, Schüler, Armin, Huschens, Susanne, Bullinger, & Monika (2025). Assessing patient-reported adverse events in oncology – a review of the PRO-CTCAE instrument. GMS Medizinische Informatik, Biometrie und Epidemiologie, 21(Doc01), Doc01. https://doi.org/10.3205/mibe000273

Vancouver

Knoerzer, Dietrich, Kron, Martina, Schüler, Armin, et al. Assessing patient-reported adverse events in oncology – a review of the PRO-CTCAE instrument. GMS Medizinische Informatik, Biometrie und Epidemiologie. 2025;21(Doc01):Doc01. doi:10.3205/mibe000273

BibTeX
@article{Knoerzer2025,
  author = {Knoerzer and Dietrich and Kron and Martina and Schüler and Armin and Huschens and Susanne and Bullinger and Monika},
  title = {Assessing patient-reported adverse events in oncology – a review of the PRO-CTCAE instrument},
  journal = {GMS Medizinische Informatik, Biometrie und Epidemiologie},
  year = {2025},
  volume = {21},
  number = {Doc01},
  pages = {Doc01},
  doi = {10.3205/mibe000273}
}
Kostenlos starten →